Pharmacy Website

Training, Program and Collaborative Grant Opportunities

NIH Notices of Intent

 NIH Opportunities
(click here for all open "P" opportunities)
(click here for all open "S" opportunities)
(click here for all open "T" opportunities)
(click here for all open "U" opportunities)

 Ancillary Studies in PREDICT-HD (U01)

The
National Institute of Neurological Disorders and Stroke (NINDS) invites
applications for ancillary studies that will further our understanding
of the unique clinical and biomarker signatures of premanifest or
prodromal Huntington's disease (HD) through coordination with the
NINDS-funded Neurobiological Predictors of Huntington's Disease
(PREDICT-HD) study. The PREDICT-HD study is an international 32-site
observational study of persons at-risk for HD, and includes clinical and
biospecimen resources from 800 premanifest HD participants and 200
healthy control subjects.  Extensive clinical data including UHDRS motor
examination, cognitive and neuropsychiatric assessments, and structural
MRI imaging have been collected over a ten-year time frame, with a
subset of these data accessible through the dbGaP website
http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs0....

Announcement #: PAR-12-097
Posted:  February 3, 2012
Funding Level:$200,000 to $499,000 per year up to 3 years
Letter of Intent Due:  onemonth before due date
Due Date:   December 11; 2013 – April 12, August 14, December 11; 2014 – April 11

Predictive Multiscale Models for Biomedical, Biological, Behavioral, Environmental and Clinical Research (Interagency U01)

 The goal of this interagency funding opportunity announcement (FOA) is to support the development of multiscale models to accelerate biological, biomedical, behavioral, environmental and clinical research. The NIH, DOE, FDA, and NSF recognize that to efficiently and effectively address the challenges of understanding multiscale biological and behavioral systems, researchers will need predictive, computational models that encompass multiple biological and behavioral scales. This FOA also encourages the development of new, non-standard modeling methods and experimental approaches to facilitate multiscale modeling.

Announcement #: PAR-11-203
Posted:  Apr 15, 2011
Funding Level: $500,000 per year up to five years
Letter of Intent Due:  30 days before due date
Due Date:     05/31/13, 09/27/13, 01/31/14

National Cooperative Drug Discovery/ Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U19)

The purpose of the National Cooperative Drug Discovery/Development Group (NCDDG) Program is to create multidisciplinary research groups or partnerships for the discovery of pharmacological agents to treat and to study mental illness, drug or alcohol addiction. The objectives of this program are to: accelerate innovative drug discovery; develop pharmacologic tools for basic and clinical research on mental disorders, or drug or alcohol addiction; develop and validate models for evaluating novel therapeutics for mental disorders; and support early phase human clinical testing to rapidly assess the safety and efficacy of promising drug candidates and new indications for IND-ready drugs for the treatment of mental disorders or alcohol addiction. The National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) invite applications to advance the discovery, preclinical development, and proof of concept testing of new, rationally based candidate medications to treat mental disorders or drug or alcohol addiction, and to develop novel ligands as tools to further characterize existing or to validate new drug targets. Partnerships between academia and industry are strongly encouraged.

Announcement #: PAR-11-207
Posted:  April 22, 2011
Funding Level:  not specified
Letter of Intent Due:  January 22, 2013
Due Date:   February 22, 2013

 

National Cooperative Drug Discovery/ Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (UM1)

The purpose of the National Cooperative Drug Discovery/Development Group (NCDDG) Program is to create multidisciplinary research groups or partnerships for the discovery of pharmacological agents to treat and to study mental illness, drug or alcohol addiction. The objectives of this program are to: accelerate innovative drug discovery; develop pharmacologic tools for basic and clinical research on mental disorders, or drug or alcohol addiction; develop and validate models for evaluating novel therapeutics for mental disorders; and support early phase human clinical testing to rapidly assess the safety and efficacy of promising drug candidates and new indications for IND-ready drugs for the treatment of mental disorders or alcohol addiction. The National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) invite applications to advance the discovery, preclinical development, and proof of concept testing of new, rationally based candidate medications to treat mental disorders or drug or alcohol addiction, and to develop novel ligands as tools to further characterize existing or to validate new drug targets. Partnerships between academia and industry are strongly encouraged.

Announcement #: PAR-11-206
Posted:   April 22, 2011
Funding Level:  Not specified
Letter of Intent Due:  January 22, 2013
Due Date:   February 22, 2013

National Cancer Institute Program Project (P01) Applications

With this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for investigator-initiated program project (P01) grants. Proposed program projects may address any of the broad areas of cancer research, including (but not limited to) cancer biology, cancer treatment, cancer diagnosis, cancer prevention, and cancer control. Basic, translational, clinical, and/or population-based studies in all of these research areas are appropriate. Each Program Project application must consist of at least three component projects. The component projects must share a common central theme, focus, and/or overall objective.

Announcement #PAR-12-005
Posted:  October 21, 2011
Funding Level:  see announcement
Letter of Intent Due:  30 days before due date
Due Date:   January 25, May 25, September 25; exp Jan 8, 2015

Support of NIGMS Program Project Grants (P01)

This funding opportunity announcement (FOA) issued by the National Institute
of General Medical Sciences encourages innovative, interactive program
project grant applications from institutions/organizations that propose
to conduct research which aims to solve a significant biological
problem, important for the mission of NIGMS, through a collaborative
approach involving outstanding scientists who might not otherwise
collaborate. The program project grant mechanism is designed to support
research in which the funding of several interdependent projects as a
group offers significant scientific advantages over support of these
same projects as individual regular research grants.

Announcement #: PAR-11-220
Posted:  May 31, 2011
Funding Level:  $500,000 annual up to five years
Letter of Intent Due:  NA
Due Date:    May 25, 2012 through 2014

NINDS Cooperative Program in Translational Research Multi-Component Research Projects (U54)

The goal of this funding opportunity announcement (FOA) is to support preclinical development and testing of new therapies for neurological disorders. The program will facilitateencouragement, development, and review of therapy-directed projects to accelerate the translation of basic research discoveries into therapeutic candidates for clinical testing. To be eligible for support, projects must include therapeutic leads and in vivo proof of concept on efficacy. The program supports preclinical optimization and testing of the leads, and projects must be sufficiently advanced that an Investigational New Drug (IND) or Investigational Device Exemption (IDE) application to the Food and Drug Administration (FDA) can be submitted by the end of the project period. The program does not support early-stage therapeutic discovery activities such as screening. The program also excludes clinical research, basic research, and studies of disease mechanism. The scope includes only therapy development activities, so development of diagnostics, biomarkers, or rehabilitation strategies cannot be supported. This is a milestone-driven cooperative agreement program involving participation of NINDS staff in the development of the project plan and monitoring of research progress.
Announcement #: PAR-11-295
Posted:  August 8, 2011
Funding Level: Not specified up to 5 years
Letter of Intent Due:  NA
Due Date:  May 25

Basic Cancer Research in Cancer Health Disparities (U01)

Through this Funding Opportunity Announcement (FOA), the Center to Reduce Cancer Health Disparities (CRCHD), the Division of Cancer Biology (DCB) and Division of Cancer Prevention (DCP), at the National Cancer Institute (NCI), encourage grant applications from investigators interested in conducting basic, mechanistic research into the biologic/genetic causes of cancer health disparities. These cooperative agreement research awards (U01) will support innovative studies designed to investigate biological/genetic bases of cancer disparities, and may include the development and testing of new methodologies and models, secondary data analyses, and mechanistic studies of identified biological factors associated with cancer disparities, including those related to basic research in prevention strategies.  This FOA is also designed to aid and facilitate the development of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research who can develop resources and tools, such as biospecimens, cell lines and methods that are necessary to conduct basic research in cancer health disparities.

Announcement #: PAR-12-095
Posted:  February 2, 2012
Funding Level: $250,000 per year up to 5 years
Letter of Intent Due:  NA
Due Date:   2013- June 20, November 20; 2014- June 20, November 20; exp. Nov. 21, 2014

HIV Vaccine Research and Design (HIVRAD) Program (P01)

Support of multi-component, multi-disciplinary projects that address important scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive modeling of vaccine concepts in non-human primates may be included.

Announcement #:PAR-12-087
Posted:  January 31, 2012
Funding Level: Approx. $1,000,000 per year up to 5 years
Letter of Intent Due:  May 13, 2012-2014
Due Date:  June 13, 2012-2014; exp. June 14, 2014

NINDS Cooperative Program in Translational Research Single-Component Research Projects (U01, U44)

The goal of this funding opportunity announcement (FOA) is to support preclinical development and testing of new therapies for neurological disorders. The program will facilitate encouragement , development, and review of therapy-directed projects to accelerate the translation of basic research discoveries into therapeutic candidates for clinical testing. To be eligible for support, projects must include therapeutic leads and in vivo proof of concept on efficacy. The program supports preclinical optimization and testing of the leads, and projects must be sufficiently advanced that an Investigational New Drug (IND) or Investigational Device Exemption (IDE) application to the Food and Drug Administration (FDA) can be submitted by the end of the project period. The program does not support early-stage therapeutic discovery activities such as screening. The program also excludes clinical research, basic research, and studies of disease mechanism. The scope includes only therapy development activities, so development of diagnostics, biomarkers, or rehabilitation strategies cannot be supported. This is a milestone-driven cooperative agreement program involving participation of NINDS staff in the development of the project plan and monitoring of research progress. 

Announcement #:PAR-11-294 (U01); PAR-11-296 (U44)
Posted: 
Funding Level: Not specified
Letter of Intent Due: NA
Due Date:  July 5, November 5, March 5; exp. Jan 8,2013

 NINDS Cooperative Program in Translational Research Single-Component Research Projects (U01)

The
goal of this funding opportunity announcement (FOA) is to support
preclinical development and testing of new therapies for neurological
disorders. The program will facilitate encouragement , development, and
review of therapy-directed projects to accelerate the translation of
basic research discoveries into therapeutic candidates for clinical
testing. To be eligible for support, projects must include therapeutic
leads and in vivo proof of concept on efficacy. The program supports
preclinical optimization and testing of the leads, and projects must be
sufficiently advanced that an Investigational New Drug (IND) or
Investigational Device Exemption (IDE) application to the Food and Drug
Administration (FDA) can be submitted by the end of the project period.
The program does not support early-stage therapeutic discovery
activities such as screening. The program also excludes clinical
research, basic research, and studies of disease mechanism. The scope
includes only therapy development activities, so development of
diagnostics, biomarkers, or rehabilitation strategies cannot be
supported. This is a milestone-driven cooperative agreement program
involving participation of NINDS staff in the development of the project
plan and monitoring of research progress.

Announcement #:  PAR-11-294
Posted:  August 8, 2011
Funding Level:  Not specified up to 5 years
Letter of Intent Due:   NA
Due Date:   July 5

 

Biomedical/Biobehavioral Research Administration Development (BRAD) Award [G11]

This Funding Opportunity Announcement (FOA) issued by The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the Fogarty International Center (FIC), and the National Institute of Allergy and Infectious Diseases (NIAID), encourages applications from eligible domestic and foreign institutions that propose to build capacity in their research administration infrastructures.  The Biomedical Biobehavioral Research Administration Capacity Development (BRAD) Program (G11) promotes the establishment of rigorous and externally supported biomedical and biobehavioral research and/or research-related training programs by providing support for strengthening institutional research administration infrastructures.  This program provides training in NIH policies and procedures through distance learning and an NIH Residency Training Program.  Additionally, funds are provided to strengthen existing or facilitate the establishment of new research administration infrastructures such as Offices of Sponsored Projects (OSP), Offices of Research and Sponsored Projects (ORSP), or components of such entities. The goal of the BRAD program is to enable eligible institutions to develop research support infrastructures that will facilitate the thorough oversight and administrative management of extramural grant awards, foster and facilitate ongoing research activities at the institution, and serve as the main organizational entity for the technical development of grant proposal submissions and oversight.

Announcement #:PAR-11-270
Posted:  July 21, 2011
Funding Level: $85,000 per year (direct costs), of which up to $20,000 must be allocated in years 4 and 5 for sustainability initiatives.  In addition, applicants may request up to $5,500 in year 1 for travel related to the NIH Residency Training.
Letter of Intent Due: June 29, 2013
Due Date:   July 31, 2013

Centers of Excellence for Research on CAM (P01)

This funding opportunity announcement (FOA) is issued by the National Center for Complementary and Alternative Medicine (NCCAM) to enable submission of applications that propose to conduct research that is of high-priority to NCCAM that requires synergistic collaboration between outstanding scientists, and the synthesis of multiple research approaches by multi-disciplinary research teams. The CERC mechanism is designed to support research in which the funding of three or four synergistic, highly meritorious projects as a group offers significant scientific advantages over support of the same projects as individual research grants.

Announcement #:PAR-12-151
Posted:  March 30, 2012
Funding Level: $1.2 million per year up to 5 years
Letter of Intent Due:  NA
Due Date:  September 25, 2013, 2014

 

FY13 NIDA Avant-Garde Award Program for HIV/AIDS Research (DP1)

The NIDA Avant-Garde Award Program for HIV/AIDS Research supports individual scientists of exceptional creativity who propose high-impact research that will open new areas of HIV/AIDS research and/or lead to new avenues for prevention and treatment of HIV/AIDS among drug abusers.  The term “avant-garde” is used to describe highly innovative approaches that have the potential to be transformative.  The proposed research should reflect approaches and ideas that are substantially different from those already being pursued by the investigator or others. The research proposed must be in an area described in the Trans – NIH Plan for HIV-Related Research http://www.oar.nih.gov/strategicplan/. 

Announcement #: RFA-DA-13-002
Posted:  April 24, 2012
Funding Level: $500,000 per year up to 5 years
Letter of Intent Due:  NA
Due Date:  January 17, 2013

 Environmental Health and Safety of Nanotechnology

The Environmental Health and Safety of Nanotechnology (Nano EHS) program provides support to examine and mitigate the environmental effects of nanotechnologies.  Fundamental research is sought to understand, evaluate, and lessen the impact of nanotechnology on the environment and biological systems.

The program emphasizes engineering principles underlying the environmental health and safety impacts of nanotechnology.  Innovative methods related to clean nanomaterials production processes, waste reduction, recycling, and industrial ecology of nanotechnology are also of interest.  

Current areas of support include:

    Understanding, measuring, mitigating, and preventing adverse effects of nanotechnology on the environment and biological systems

    Nanotechnology environmental health and safety impacts

    Predictive methodology for the interaction of nanoparticles with the environment and with the human body, including predictive approaches for toxicity

    Fate and transport of engineered nanoparticles and their by-products

    Risk assessment and management of the effect of nanomaterials in the environment

Announcement #:PD 13-1179
Posted:  April 19, 2012
Funding Level: $100,000 per year up to 3 years
Letter of Intent Due: NA
Due Date: January 15, 2013 - February 19, 2013

 All Open Program Opportunities

 

Announcement
Number
Related
Announc.
Issuing
Organization
Release
Date
Opening Date
(SF424 Only)
Opening Date is the earliest date an electronic application may be submitted to Grants.gov - Applies only to SF424 electronic applications. Click on Question Mark for more information.
Expiration
Date
Activity
Code(s)
Title
RFA-AR-14-002
See Related

NIAMS 01/23/2013

n/a

07/02/2013

P30

Core Centers for Musculoskeletal Biology and Medicine (P30)
RFA-DK-12-023
See Related

NIDDK 01/04/2013

n/a

11/16/2013

P30

Silvio O. Conte Digestive Diseases Research Core Centers (P30)
PAR-13-068
See Related

NCI 12/21/2012

n/a

03/20/2015

P20

Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20)
PAR-13-062
See Related

NIDCD 12/20/2012

n/a

10/02/2015

P50

NIDCD Clinical Research Center Grant (P50)
RFA-OD-12-007
See Related

NIH 12/18/2012

n/a

03/27/2013

P30

NIH Revision Applications for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (P30)
RFA-DK-12-020
See Related

NIDDK 12/12/2012

02/28/2013

03/29/2013

DP3

Diabetes Impact Award-Closed Loop Technologies: Clinical,
Physiological and Behavioral Approaches to Improve Type 1 Diabetes
Outcomes (DP3)
RFA-DK-12-021
See Related

NIDDK 12/12/2012

02/28/2013

03/29/2013

DP3

Diabetes Impact Award-Closed Loop Technologies: Development and
Integration of Novel Components for an Automated Artificial Pancreas
System (DP3)
RFA-ES-13-002
See Related

NIEHS 11/28/2012

01/14/2013

02/14/2013

P30

Environmental Health Sciences (EHS) Core Centers (P30)
PAR-13-028
See Related

NIDDK 11/27/2012

03/02/2013

04/03/2013

DP3

Research Using Subjects From Selected Type 1 Diabetes Clinical Studies (Living Biobank) (DP3)
PAR-13-024
See Related

NIDCD 11/23/2012

n/a

10/02/2015

P30

NIDCD Research Core Centers (P30)
RFA-NS-13-006
See Related

NINDS 11/23/2012

12/23/2012

01/24/2013

P50

Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50)
RFA-ES-13-001
See Related

NIEHS 11/15/2012

03/08/2013

04/11/2013

P42

Superfund Hazardous Substance Research and Training Program (P42)
RFA-DK-12-022
See Related

NIDDK 11/05/2012

n/a

02/28/2013

P20

Developmental Centers for Interdisciplinary Research in Benign Urology (P20)
PAR-13-013
See Related

NIDDK 10/30/2012

03/02/2013

04/03/2013

DP3

Research Using Biosamples from Selected Type 1 Diabetes Clinical Studies (DP3)
PAR-12-298
See Related

NCI 09/26/2012

n/a

01/08/2016

P30

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30)
PAR-12-296
See Related

NCI 09/25/2012

n/a

09/24/2014

P50

Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2013 and 2014 (P50)
PAR-12-290
See Related

NCI 09/19/2012

n/a

06/19/2015

P01

Revisions for Early-Stage Development of Informatics Technology (P01)
PAR-12-272
See Related

NIA 08/27/2012

n/a

05/08/2015

P30

National Institute on Aging: Revision Requests for Active Alzheimer's Disease Core Centers (P30)
RFA-RM-12-018
See Related

Roadmap 07/13/2012

12/30/2012

01/31/2013

DP5

NIH Director's Early Independence Awards (DP5)
PAR-12-224
See Related

NIGMS 07/10/2012

n/a

09/26/2014

P20

Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE)[P20]
PAR-12-205
See Related

NIGMS 06/12/2012

n/a

06/21/2014

P20

IDeA Networks of Biomedical Research Excellence (INBRE) [P20]
PAR-12-187
See Related

NIGMS 05/16/2012

n/a

10/24/2014

P50

NIGMS National Centers for Systems Biology (P50)
PA-12-170
See Related

NIA 04/20/2012

n/a

05/08/2015

P50

National Institute on Aging: Revision Requests for Active Alzheimer's Disease Centers (P50)
PA-12-159
See Related

NIDCR 04/11/2012

05/11/2012

06/01/2014

P01, R01, R15, R37, U01, U54

Administrative Supplements for Collaborative Science:
Opportunities for Existing NIDCR Grants and Cooperative Agreements
(Admin Supp)
PA-12-149
See Related

NIH 04/06/2012

04/06/2012

09/30/2015

DP1, DP2, DP3, DP4, DP5, G12, K99/R00, P01, P20, P30,
P40, P41, P50, P60, R01, R03, R15, R18, R21, R24, R34, R37, R41, R42,
R43, R44, RC1, RC2, RC3, RC4, SC1, SC2, SC3, U01, U10, U18, U19, U34,
U41, U42, U54, UM1, UP5

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp)
PA-12-150
See Related

NIH 04/06/2012

04/06/2012

09/30/2015

DP1, DP2, DP3, DP4, DP5, G12, P01, P20, P30, P40, P41,
P50, P51, P60, R01, R18, R24, R34, R37, R41, R42, R43, R44, RC1, RC2,
RC3, RC4, U01, U10, U18, U19, U34, U41, U42, U54, UM1, UP5

Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp)
PAR-12-151
See Related

NCCAM 03/30/2012

n/a

01/08/2015

P01

Centers of Excellence for Research on CAM (P01)
PAR-12-087
See Related

NIAID 01/31/2012

n/a

06/14/2014

P01

HIV Vaccine Research and Design (HIVRAD) Program (P01)
PAR-12-034
See Related

NICHD 11/21/2011

n/a

01/08/2015

P01

Developmental Mechanisms of Human Structural Birth Defects (P01)
PAR-12-005
See Related

NCI 10/21/2011

n/a

01/08/2015

P01

National Cancer Institute Program Project (P01) Applications
PAR-11-286
See Related

NIGMS 08/01/2011

n/a

02/22/2014

P20

Centers of Biomedical Research Excellence (COBRE) (P20)
PAR-11-220
See Related

NIGMS 05/31/2011

n/a

09/08/2014

P01

Support of NIGMS Program Project Grants (P01)
PAR-11-188
See Related

NIAMS 03/31/2011

n/a

05/08/2014

P01

Support of NIAMS Program Project Grants (P01)
PAR-11-172
See Related

NINDS 03/22/2011

n/a

05/08/2014

P01

NINDS Program Project Grant (P01)
PAR-11-136
See Related

ORIP 03/09/2011

n/a

05/08/2014

P51

Limited Competition: National Primate Research Centers (P51)
PAR-11-126
See Related

NIMH 02/16/2011

n/a

05/26/2013

P50

Silvio O. Conte Centers for Basic and Translational Mental Health Research (P50)
PAR-11-108
See Related

NIAID 02/09/2011

n/a

06/15/2013

P30

Centers for AIDS Research and Developmental Centers for AIDS Research (P30)
PAR-11-066
See Related

NIA 12/08/2010

n/a

09/08/2013

P01

NIA Program Project Applications (P01)
PAR-11-043
See Related

NIDDK 11/22/2010

n/a

01/08/2014

P01

NIDDK Program Project Applications (P01)
PAR-11-019
See Related

NIMH 11/05/2010

n/a

09/08/2013

P30

Centers Program for Research on HIV/AIDS and Mental Health (P30)
PAR-11-005
See Related

NCI 10/12/2010

n/a

09/08/2013

P30

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30)
PAR-11-001
See Related

ORIP 10/01/2010

n/a

09/08/2013

P40

Animal and Biological Material Resource Centers (P40)
PAR-10-285
See Related

NHLBI 09/21/2010

n/a

09/08/2013

P01

NHLBI Program Project Applications (P01)
PAR-10-284
See Related

NIA 09/20/2010

n/a

09/08/2013

P01

National Institute on Aging: Revision Requests for Active Program Projects (P01)
PAR-10-271
See Related

NIAID 08/20/2010

n/a

09/08/2013

P01

NIAID Investigator Initiated Program Project Applications (P01)
PAR-10-244
See Related

NIDA 08/03/2010

n/a

09/08/2013

P01

NIDA Program Project Grant Applications (P01)
PAR-10-245
See Related

NICHD 08/03/2010

n/a

09/08/2013

P01

NICHD Program Project Grant (P01)
PAR-10-233
See Related

NIBIB 07/20/2010

n/a

05/26/2013

P01

National Institute of Biomedical Imaging and Bioengineering Program Project (P01) Applications
PAR-10-225
See Related

NIGMS 06/30/2010

n/a

09/08/2013

P41

Biomedical Technology Research Center (P41)
PAR-10-220
See Related

NIDA 06/22/2010

n/a

01/08/2014

P30

NIDA Core Center of Excellence Grant Program (P30)
PAR-10-153
See Related

NIBIB 03/25/2010

n/a

05/08/2013

P41

NIBIB Biomedical Technology Resource Centers (P41)

PAR-10-075
See Related

NIGMS 01/05/2010

n/a

05/08/2013

P01

Technology Development for Protein Modeling (P01)
PAR-10-074
See Related

NIGMS 01/04/2010

n/a

05/08/2013

P01

Technology Development for High-Throughput Structural Biology Research (P01)

TRAINING 

Ruth L. Kirschstein National Research Service Award Short-Term Institutional Research Training Grants (Parent T35)

The
National Institutes of Health (NIH) will award Ruth L. Kirschstein
National Research Service Award (NRSA) Short-Term Institutional Research
Training Grants (T35) to eligible institutions to develop or enhance
research training opportunities for predoctoral and postdoctoral level
individuals interested in careers in biomedical, behavioral and clinical
research. Many of the NIH Institutes and Centers (ICs) use this grant
mechanism exclusively to support intensive, short-term research training
experiences for students in health professional schools during the
summer. In addition, the Short-Term Institutional Research Training
Grant may be used to support other types of predoctoral and postdoctoral
training in focused, often emerging scientific areas relevant to the
mission of the funding IC. The proposed training must be in basic,
behavioral or clinical research aspects of the health-related sciences.
This program is intended to encourage graduate and/or health
professional students to pursue research careers by exposure to and
short-term involvement in the health- related sciences. The training
should be of sufficient depth to enable the trainees, upon completion of
the program, to have a thorough exposure to the principles underlying
the conduct of research.  Awards for T35 Short-Term institutional NRSA
research training grants may be for project periods up to five years in
duration and are renewable.  Trainees selected for short-term training
are required to pursue research training for 2-3 months on a full-time
basis..

Announcement #:  PA-11-185
Posted:  March 25, 2011
Funding Level: Various (see announcement for stipend aounts)
Letter of Intent Due:  NA
Due Date:  January 25, May 25, September 25

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (Parent T32)

The
National Institutes of Health (NIH) will award Ruth L. Kirschstein
National Research Service Award (NRSA) Institutional Research Training
Grants (T32) to eligible institutions as the primary means of supporting
predoctoral and postdoctoral research training to help ensure that a
diverse and highly trained workforce is available to assume leadership
roles related to the Nation’s biomedical, behavioral and clinical
research agenda.  The objective of the T32 program is to prepare
qualified individuals for careers that have a significant impact on the
health-related research needs of the Nation. This program supports
predoctoral and postdoctoral research training programs (including those
with short term research training) at domestic institutions of higher
education with the T32 funding mechanism.  Note that programs solely for
short-term research training should not apply to this announcement, but
rather the separate (T35) NRSA Short-Term Institutional program
exclusively reserved for predoctoral and/or postdoctoral level
short-term research training programs (see PA-11-185).

Announcement #:  PA-11-184
Posted:  March 25, 2011
Funding Level: Various (see announcement for stipend aounts)
Letter of Intent Due:  NA
Due Date:  January 25, May 25, September 25


 

 NSF Opportunities

Innovation Corps Program

 (I-Corps)

 The National Science Foundation (NSF) seeks to develop and nurture a
national innovation ecosystem that builds upon fundamental research to
guide the output of scientific discoveries closer to the development of
technologies, products and processes that benefit society.

In
order to jumpstart a national innovation ecosystem, NSF is establishing
the NSF Innovation Corps (NSF I-Corps). The NSF I-Corps' purpose is to
identify NSF-funded researchers who will receive additional support - in
the form of mentoring and funding - to accelerate innovation that can
attract subsequent third-party funding.  

The purpose of the NSF
I-Corps grant is to give the project team access to resources to help
determine the readiness to transition technology developed by
previously-funded or currently-funded NSF projects.  The outcome of the
I-Corps projects will be threefold: 1) a clear go/no go decision
regarding viability of products and services, 2) should the decision be
to move the effort forward, a transition plan to do so, and 3) a
technology demonstration for potential partners. 

Due Dates:
Full Proposal Window:  January 1, 2012

-
March 15, 2012

January 1 - March 15, Annually Thereafter

Full Proposal Window:  April 1, 2012

-
June 15, 2012

April 1 - June 15, Annually Thereafter

Full Proposal Window:  July 1, 2012

-
September 15, 2012

July 1 - September 15, Annually Thereafter

Full Proposal Window:  October 1, 2012

-
December 15, 2012

October 1 - December 15, Annually Thereafter

Full Proposal Window:  January 1, 2013

-
March 15, 2013

January 1 - March 15, Annually Thereafter